Toxys is a Dutch biotech company specializing in innovative chemical safety testing services. Their unique combination of mechanism-based in vitro assays, such as ToxTracker, and their expertise in genotoxicity allows them to provide sponsors with comprehensive information on the toxicity of their compounds. The ToxTracker suite, a collection of in vitro genotoxicity assays, provides detailed insights into the mode of action of genotoxic compounds.

Additionally, ReproTracker, a novel in vitro developmental toxicity assay, uses human induced pluripotent stem cells to assess early embryonic development and identify teratogens. Toxys also offers screening and mechanistic genotoxicity testing services that can be used as early screening tools or for validating test results. They continuously develop state-of-the-art in vitro systems that provide mechanistic understanding of toxicity, focusing on stem cells and the latest reporter technologies.

By rapidly identifying hazardous and potential carcinogenic properties of compounds during early phases of product and drug development, Toxys contributes to the development of better medicines and products while reducing the need for animal testing. They are trusted by a range of customers, from pharmaceutical companies to start-ups, and their in-house screening capabilities combined with their responsiveness make them a preferred partner in the industry